Daiwa Securities Group Inc. boosted its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 14.6% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 105,791 shares of the company’s stock after buying an additional 13,450 shares during the period. Daiwa Securities Group Inc.’s holdings in Colgate-Palmolive were worth $10,983,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. 1832 Asset Management L.P. lifted its position in shares of Colgate-Palmolive by 4,847.3% in the first quarter. 1832 Asset Management L.P. now owns 9,301 shares of the company’s stock worth $838,000 after buying an additional 9,113 shares in the last quarter. Industrial Alliance Investment Management Inc. raised its holdings in shares of Colgate-Palmolive by 4.4% during the 1st quarter. Industrial Alliance Investment Management Inc. now owns 4,185 shares of the company’s stock worth $377,000 after acquiring an additional 176 shares in the last quarter. B. Riley Wealth Advisors Inc. boosted its position in shares of Colgate-Palmolive by 0.8% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock valued at $1,498,000 after acquiring an additional 138 shares during the last quarter. California State Teachers Retirement System increased its position in Colgate-Palmolive by 0.8% in the first quarter. California State Teachers Retirement System now owns 1,301,518 shares of the company’s stock worth $117,202,000 after purchasing an additional 9,979 shares during the last quarter. Finally, Tidal Investments LLC raised its stake in Colgate-Palmolive by 31.1% during the first quarter. Tidal Investments LLC now owns 61,646 shares of the company’s stock valued at $5,551,000 after purchasing an additional 14,631 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.34% of the stock is currently owned by insiders.
Colgate-Palmolive Stock Up 0.7 %
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.
Analysts Set New Price Targets
A number of analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their target price for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. TD Cowen decreased their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Finally, Sanford C. Bernstein increased their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a report on Tuesday, July 30th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $105.11.
Read Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- About the Markup Calculator
- 3 Top-Performing U.S.-Traded Emerging Market Stocks in 2024
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Disney’s Magic Strategy: Reinventing the House of Mouse
- The Significance of Brokerage Rankings in Stock Selection
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.